MiMedx Group, Inc. the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts with...
Read moreGlobal biotherapeutics leader CSL announced that it will proceed with a Phase 3 clinical trial for CSL112, the company’s novel...
Read moreGlaxoSmithKline plc announced that new data from a Phase III clinical study supports the safety and efficacy of Shingrix (Zoster...
Read moreBayer and Loxo Oncology, Inc., a biopharmaceutical company based in Stamford, Connecticut, US, announced updated clinical data from the larotrectinib...
Read moreNovo Nordisk announced that the U.S. Food and Drug Administration (FDA) approved its New Drug Application (NDA) for OZEMPIC® (semaglutide)...
Read moreJohnson & Johnson announced that Janssen Vaccines & Prevention BV, part of the Janssen Pharmaceutical Companies, is working in partnership...
Read moreResearchers report creating a biologically accurate mass-production platform that overcomes major barriers to bioengineering human liver tissues suitable for therapeutic...
Read moreDNAtrix, a leader in the development of oncolytic virus immunotherapies for cancer, announced the intratumoral delivery of DNX-2401 to the...
Read moreBayer has extended its ongoing research collaboration with the Broad Institute of MIT and Harvard in the US by five...
Read moreAMPEL BioSolutions, a leading biomedical research firm based in Charlottesville, Va., Horizon Pharma plc and The Lupus Research Alliance today...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.